Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas - Related Studies

Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas

This study is currently recruiting participants.

Study NCT00555464. Last updated on July 1, 2008. Information provided by FDA Office of Orphan Products Development

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Hemangioma

2	More general conditions related to this trial
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms, Vascular Tissue

3	Interventions listed in this trial
		Vincristine
		Prednisone

4	Additional drug interventions recognized in this trial
		Methylprednisolone
		Methylprednisolone acetate
		Methylprednisolone Hemisuccinate
		Prednisolone
		Prednisolone acetate

5	More general drug interventions related to this trial
		Anti-Inflammatory Agents
		Antiemetics
		Antimitotic Agents
		Antineoplastic Agents
		Antineoplastic Agents, Hormonal
		Antineoplastic Agents, Phytogenic
		Autonomic Agents
		Central Nervous System Agents
		Gastrointestinal Agents
		Glucocorticoids
		Hormones
		Hormones, Hormone Substitutes, and Hormone Antagonists
		Mitosis Modulators
		Molecular Mechanisms of Pharmacological Action
		Neuroprotective Agents
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Protective Agents
		Therapeutic Uses
		Tubulin Modulators

6	Sponsors listed in this trial
		FDA Office of Orphan Products Development
		Medical College of Wisconsin
		University of California, San Francisco
		Indiana University